The Mumps Virus Neurovirulence Safety Test in Rhesus Monkeys:A Comparison of Mumps Virus Strains
Citations Over TimeTop 13% of 1999 papers
Abstract
Wild type mumps viruses are highly neurotropic and a frequent cause of aseptic meningitis in unvaccinated humans. To test whether attenuated mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey neurovirulence safety test (MNVT) is performed. However, results with several mumps virus MNVTs have raised questions as to whether the test can reliably discriminate neurovirulent from nonneurovirulent mumps virus strains. Here, various mumps virus strains representing a wide range of neuropathogenicity were tested in a standardized MNVT. A trend of higher neurovirulence scores was observed in monkeys inoculated with wild type mumps virus versus vaccine strains, although differences were not statistically significant. Results indicated the need for further examination and refinement of the MNVT or for development of alternative MNVTs.
Related Papers
- → The Mumps Virus Neurovirulence Safety Test in Rhesus Monkeys:A Comparison of Mumps Virus Strains(1999)44 cited
- → Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene(1990)39 cited
- → Cases of aseptic meningitis after vaccination against mumps in Russia (2009–2019)(2020)4 cited
- → Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing(1990)51 cited
- [Growth of mumps virus in human lung carcinoma cell lines. I. Host-range variant adapted under the presence of anti-mumps virus antibody (author's transl)].(1981)